Analystreport

Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.

SIENNA BIOPHARMACEUTICALS  (SNNA) 
Last sienna biopharmaceuticals earnings: 8/8 04:18 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.siennabio.com/node/5806